Detalles de la búsqueda
1.
The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.
Cancer;
128(1): 169-179, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34490624
2.
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.
Hum Reprod;
36(4): 1120-1133, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33582778
3.
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study.
Pharmacogenomics J;
20(2): 294-305, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666714
4.
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
Lancet Oncol;
20(1): e29-e41, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30614474
5.
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol.
BMC Cancer;
18(1): 930, 2018 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30257669
6.
Health-related fitness in very long-term survivors of childhood cancer: A cross-sectional study.
Pediatr Blood Cancer;
65(4)2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29271565
7.
Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.
Pediatr Hematol Oncol;
34(2): 120-129, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28590156
8.
Inter-individual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE.
Fertil Steril;
2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729340
9.
A comparison of genotyping arrays.
Eur J Hum Genet;
29(11): 1611-1624, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34140649
10.
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study.
Cancers (Basel);
13(18)2021 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34572825
11.
Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study.
Neurooncol Adv;
2(1): vdaa122, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33196041
12.
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
Eur J Cancer;
138: 212-224, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32905960
13.
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset.
Data Brief;
32: 106227, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32939381
14.
Tinnitus during and after childhood cancer: A systematic review.
Crit Rev Oncol Hematol;
135: 1-7, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819438
15.
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study.
JMIR Res Protoc;
8(3): e11868, 2019 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30888333
16.
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents.
Eur J Cancer;
103: 227-237, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30273888
17.
Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Eur J Cancer;
69: 77-85, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821322
Resultados
1 -
17
de 17
1
Próxima >
>>